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Background
Antibody-mediated rejection (AMR) is characterized by
histopathological and immunophenotypic findings such as
activated endothelial cells, intravascular macrophages and
evidence of capillary C4d deposition. This inflammatory
reaction could be followed by diffuse fibrosis. Cardiac
magnetic resonance (CMR) with recently T1 mapping is a
promising technique to identify diffuse myocardial fibrosis.
The purpose of this study was to assess T1 mapping in
patients with AMR.
Methods
Two patients with clinical AMR (histopathological and
immunophenotypic findings, presence of donor-specific
allo antibodies and allograft dysfunction) performed a
CMR study one week (for the first patient) and 3 weeks
(for the second patient) after the treatment of AMR (plas-
mapheresis, IV Immunoglobulins and Rituximab). Images
were acquired on a 1.5 Tesla scanner (Siemens) including
T1 mapping using a shortened modified look-locker inver-
sion-recovery sequence and T2 mapping in a matched
mid-ventricular short axis slice using a black- blood single
shot fast spin echo pulse sequence. Segmental and global
T1 values were measured before and 15 minutes after
administration of 0.2 mmol/kg of Gadoteric acid and
compared to our cohort of 17 controls.
Results
Mean non contrast T1 values were significantly higher
in heart transplants patients compared to controls (1100
± 5 ms vs 947 ± 29 ms, P < 0.001). Segmental T1 values
were significantly higher in the 6 regions of interest
compared to controls (P < 0.001 in all segments). Mean
post contrast T1 values were not significantly different
in patients and controls. Mean T2 value was higher in
patients compared to controls (73 ± 13 vs 50 ± 4 ms),
suggesting the presence of global edema.
Conclusions
Heart transplant patients with clinical antibody-
mediated rejection show a significant increased global
and segmental non contrast T1 values suggesting the
presence of diffuse myocardial fibrosis. Further studies
are required to confirm these data.
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